Indication
Chronic Mucocutaneous Candidiasis
1 clinical trial
1 drug
Clinical trial
Rituximab (Anti-CD20) for the Treatment of Subjects With Anticytokine Autoantibody-Associated DiseasesStatus: Completed, Estimated PCD: 2021-05-06
Drug
Varlilumab1 clinical trial
1 drug